In addition, each contingent showed its own pathogenic variants, such as BCL2, KMT2D, EP300 in the follicular lymphoma contingent, and XPO1, TNFAIP3, and CREBBP in the cHL contingent [10]. The gene discussed is BCL2; the disease is follicular lymphoma.